Position in HIMS
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$5,634,554
-$6,005,194 QoQ
Shares Held
271,414
-24.3% QoQ
Ownership
0.117%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2022
14 quarters on record
Voting authority
Sole 19%
Shared 0%
None 81%
Common Shares in HIMS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026FIRST TRUST ADVISORS LP holds $590,881,836 across 26 Drug Manufacturers - Specialty & Generic names. HIMS ranks #12 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
270,578 | $160,447,342 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
959,217 | $126,367,247 | |
| 3 | ALKS |
Alkermes plc.
|
2,968,785 | $104,976,237 | |
| 4 | ZTS |
Zoetis Inc.
|
570,393 | $67,426,156 | |
| 5 | TAK |
Takeda Pharmaceutical Co Ltd
|
1,971,074 | $36,504,290 | |
| 6 | PRGO |
PERRIGO Co plc
|
1,496,244 | $16,069,660 | |
| 7 | LQDA |
Liquidia Corp
|
279,475 | $10,547,386 | |
| 8 | AMRX |
Amneal Pharmaceuticals, Inc.
|
757,157 | $9,411,461 |
All Filings in HIMS
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,634,554 | 271,414 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $11,639,748 | 358,477 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $9,533,781 | 168,085 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $12,530,944 | 251,373 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $9,980,305 | 337,743 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $8,586,390 | 355,103 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $4,463,737 | 242,331 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $7,521,178 | 372,520 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $8,387,478 | 542,177 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $2,648,818 | 297,620 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $2,597,958 | 413,030 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $3,772,925 | 401,375 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $6,149,318 | 619,891 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $4,348,505 | 678,394 | Shares | Sole | 2023-02-09 | |
| No filing history on record for this holder in this stock. | ||||||